Lyons Wealth Management LLC. acquired a new position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 9,924 shares of the pharmacy operator’s stock, valued at approximately $677,000. Walgreens Boots Alliance makes up about 2.2% of Lyons Wealth Management LLC.’s investment portfolio, making the stock its 18th biggest holding.
Several other large investors have also recently made changes to their positions in the company. Parametrica Management Ltd bought a new position in Walgreens Boots Alliance in the 4th quarter valued at $355,000. O Shaughnessy Asset Management LLC raised its position in shares of Walgreens Boots Alliance by 71.9% during the fourth quarter. O Shaughnessy Asset Management LLC now owns 564,092 shares of the pharmacy operator’s stock worth $38,570,000 after acquiring an additional 235,914 shares during the last quarter. Riverview Trust Co bought a new stake in shares of Walgreens Boots Alliance during the fourth quarter worth $88,000. Mn Services Vermogensbeheer B.V. raised its position in shares of Walgreens Boots Alliance by 5.8% during the fourth quarter. Mn Services Vermogensbeheer B.V. now owns 143,155 shares of the pharmacy operator’s stock worth $8,557,000 after acquiring an additional 7,900 shares during the last quarter. Finally, Martingale Asset Management L P bought a new stake in shares of Walgreens Boots Alliance during the fourth quarter worth $13,302,000. 62.52% of the stock is currently owned by institutional investors.
Shares of WBA stock traded up $0.38 on Friday, hitting $62.21. 3,833,831 shares of the stock were exchanged, compared to its average volume of 5,894,229. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.80 and a quick ratio of 0.36. The stock has a market capitalization of $58.26 billion, a P/E ratio of 10.33, a P/E/G ratio of 1.00 and a beta of 0.88. Walgreens Boots Alliance Inc has a fifty-two week low of $59.07 and a fifty-two week high of $86.31.
Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, December 20th. The pharmacy operator reported $1.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.43 by $0.03. Walgreens Boots Alliance had a return on equity of 22.17% and a net margin of 3.96%. The business had revenue of $33.79 billion for the quarter, compared to analyst estimates of $33.90 billion. During the same quarter in the prior year, the company posted $1.28 earnings per share. Walgreens Boots Alliance’s revenue was up 9.9% on a year-over-year basis. Equities analysts expect that Walgreens Boots Alliance Inc will post 6.41 EPS for the current year.
The business also recently announced a quarterly dividend, which was paid on Tuesday, March 12th. Investors of record on Friday, February 15th were issued a dividend of $0.44 per share. The ex-dividend date was Thursday, February 14th. This represents a $1.76 annualized dividend and a yield of 2.83%. Walgreens Boots Alliance’s payout ratio is presently 29.24%.
A number of equities research analysts have recently weighed in on WBA shares. Zacks Investment Research downgraded Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research report on Monday, November 26th. Morgan Stanley upped their price objective on Walgreens Boots Alliance from $55.00 to $77.00 and gave the company an “equal weight” rating in a report on Monday, December 3rd. Goldman Sachs Group downgraded Walgreens Boots Alliance from a “neutral” rating to a “sell” rating in a report on Friday, December 14th. BidaskClub downgraded Walgreens Boots Alliance from a “strong-buy” rating to a “buy” rating in a report on Tuesday, December 18th. Finally, Wolfe Research reiterated a “peer perform” rating on shares of Walgreens Boots Alliance in a report on Wednesday, December 19th. Six research analysts have rated the stock with a sell rating, ten have issued a hold rating and five have assigned a buy rating to the stock. The company has an average rating of “Hold” and a consensus price target of $77.94.
ILLEGAL ACTIVITY WARNING: This article was reported by Fairfield Current and is the property of of Fairfield Current. If you are reading this article on another domain, it was copied illegally and republished in violation of United States and international trademark and copyright law. The correct version of this article can be read at https://www.fairfieldcurrent.com/news/2019/03/15/9924-shares-in-walgreens-boots-alliance-inc-wba-acquired-by-lyons-wealth-management-llc.html.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.